Table 2.
Characteristics of linked patients by organ transplanted
| Heart N=3,046 |
Small Bowel N=305 |
Heart Lung N=45 |
Lung N=577 |
Liver N=4,714 |
Kidney N=4,701 |
|
|---|---|---|---|---|---|---|
| Age | ||||||
| <1 year | 933 (30.6%) | 52 (17.1%) | 5 (10.9%) | 50 (8.7%) | 1294 (27.5%) | 2 (<0.1%) |
| 1–5 years | 729 (23.9%) | 159 (52.1%) | 7 (15.2%) | 81 (14%) | 1796 (38.1%) | 888 (18.9%) |
| 6–10 years | 431 (14.2%) | 46 (15.1%) | 4 (8.7%) | 103 (17.9%) | 656 (13.9%) | 827 (17.6%) |
| 11–17 years | 876 (28.8%) | 40 (13.1%) | 29 (63%) | 317 (54.9%) | 920 (19.5%) | 2548 (54.2%) |
| 18–21 years | 77 (2.5%) | 8 (2.6%) | 1 (2.2%) | 26 (4.5%) | 48 (1%) | 436 (9.3%) |
| Male sex | 1657 (54.4%) | 177 (58%) | 22 (48.9%) | 247 (42.8%) | 2334 (49.5%) | 2749 (58.5%) |
| Race | ||||||
| Caucasian | 1798 (59%) | 207 (67.9%) | 34 (75.6%) | 409 (70.9%) | 2663 (56.5%) | 2131 (45.3%) |
| African American | 561 (18.4%) | 48 (15.7%) | 2 (4.4%) | 40 (6.9%) | 636 (13.5%) | 852 (18.1%) |
| Hispanic | 513 (16.8%) | 41 (13.4%) | 8 (17.8%) | 101 (17.5%) | 990 (21%) | 1421 (30.2%) |
| Other | 174 (5.7%) | 9 (3%) | 1 (2.2%) | 27 (4.7%) | 425 (9%) | 297 (6.3%) |
| Blood type | ||||||
| O | 1377 (45.2%) | 142 (46.6%) | 17 (37.8%) | 250 (43.3%) | 2283 (48.4%) | 2386 (51.3%) |
| A | 1148 (37.7%) | 108 (35.4%) | 22 (48.9%) | 220 (38.1%) | 1612 (34.2%) | 1529 (32.9%) |
| B | 393 (12.9%) | 38 (12.5%) | 3 (6.7%) | 79 (13.7%) | 622 (13.2%) | 593 (12.7%) |
| AB | 128 (4.2%) | 17 (5.6%) | 3 (6.7%) | 28 (4.9%) | 197 (4.2%) | 143 (3.1%) |
| Era | ||||||
| 2002–2009 | 1366 (44.8%) | 212 (69.5%) | 25 (55.6%) | 289 (50.1%) | 1939 (41.1%) | 1789 (38.1%) |
| 2010–2018* | 1680 (55.2%) | 93 (30.5%) | 20 (44.4%) | 288 (49.9%) | 2775 (58.9%) | 2912 (61.9%) |
| Diagnosis | ||||||
| CM 1404 (46.6%) | Short gut 203 (66.6%) | PHN 28 (62.2%) | CF 286 (49.6%) | Biliary atresia 1796 (38.1%) | Congenital 1870 (39.8%) | |
| CHD 1439 (47.8%) | FBD 68 (22.3%) | CHD 10 (22.2%) | PHN 109 (18.9%) | Metabolic 723 (15.3%) | Glomerular 1198 (25.5%) | |
| ReTx 168 (5.5%) | Other 34 (11.1%) | Other 7 (15.6%) | Other 182 (31.5%) | Hepatic failure 530 (11.2%) | Tubular/interstitial 365 (7.8%) | |
| Other 35 (1.1%) | Malignancy 439 (9.3%) | Familial/genetic 362 (7.7%) | ||||
| Cirrhosis 285 (6%) | Other 906 (19.3%) | |||||
| Other 941 (20%) | ||||||
Abbreviations: CF – Cystic fibrosis; CHD – Congenital heart disease; CM – Cardiomyopathy; FBD – Functional bowel disorder; PHN – Pulmonary hypertension; ReTx – Retransplant
*
Era 2 includes 2010 – 2018 for all groups except heart transplant (2010 – 2016)